Ad
ADMA Stock - ADMA Biologics Inc Stock Trading
About | ADMA Biologics Inc (NASDAQ:ADMA)
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.
Quote | ADMA Biologics Inc (NASDAQ:ADMA)
| Last: | $19.63 |
|---|---|
| Change Percent: | -0.94% |
| Open: | $19.39 |
| Close: | $19.63 |
| High: | $19.88 |
| Low: | $19.3 |
| Volume: | 1,595,771 |
| Last Trade Date Time: | 12/11/2024 03:00:00 am |
News | ADMA Biologics Inc (NASDAQ:ADMA)
-
2024-12-02 08:30:30 ET Summary ADMA Biologics is a rapidly growing player in plasma-derived therapies, with a 78% YoY revenue increase and a 1,300% YoY net income boost. The company’s key product, ASCENIV, is expected to drive significant revenue growth and improve margins,...
-
2024-11-27 08:15:00 ET Summary Performance was driven by investors’ rotation out of the artificial intelligence and technology-related stocks that had led for much of 2024 and into small-cap stocks. The US small-cap universe rose during the third quarter, outpacing US large...
Message Board Posts | ADMA Biologics Inc (NASDAQ:ADMA)
| Subject | By | Source | When |
|---|---|---|---|
| $ADMA Adma Biologics Inc | mick | investorshub | 04/30/2023 9:11:34 PM |
| ad-ma $ADMA | mick | investorshub | 04/15/2023 3:16:50 PM |
| $ADMA Adma Biologics Inc | mick | investorshub | 02/27/2023 12:15:20 AM |
| Looks like a double pointed top forming I | bude | investorshub | 02/09/2023 3:08:09 PM |
| Look at the weekly and monthly charts for | bude | investorshub | 02/09/2023 1:42:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
ADMA Biologics, Inc. (NASDAQ: ADMA) is the focus of IBN's latest stock spotlight. The company's shares have moved -0.97% on the day to $22.4. ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatm...
-
3Q 2024 Total Revenue of $119.8 Million, a 78% Increase Y-o-Y 3Q 2024 GAAP Net Income of $35.9 Million, a 1,300% Increase Y-o-Y 3Q 2024 Adjusted EBITDA ( 1) of $45.4 Million, a 256% Increase Y-o-Y KPMG LLP Engaged as New Independent Registered Public Ac...
-
Cognition Therapeutics Inc. (CGTX) is expected to report $-0.23 for Q3 2024 Archer Aviation Inc. Class A (ACHR) is expected to report $-0.3 for Q3 2024 Aena S.M.E. S.A. ADR (ANYYY) is expected to report $0.47 for Q3 2024 CURO Group Holdings Corp. (CUROQ) is expected to report for Q3 2...